Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Lafreniere-Roula, Yoav Bolkier, Laura Zahavich, J. Mathew, K. George, Judith Wilson, E. Stephenson, L. Benson, C. Manlhiot, S. Mital (2019)
Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?European Heart Journal, 40
( Graf J , MühlhoffC, DoigGS, ReinartzS, BodeK, DujardinR, KochKC, RoebE, JanssensU. Health care costs, long-term survival, and quality of life following intensive care unit admission after cardiac arrest. Crit Care2008;12:R92.18638367)
Graf J , MühlhoffC, DoigGS, ReinartzS, BodeK, DujardinR, KochKC, RoebE, JanssensU. Health care costs, long-term survival, and quality of life following intensive care unit admission after cardiac arrest. Crit Care2008;12:R92.18638367Graf J , MühlhoffC, DoigGS, ReinartzS, BodeK, DujardinR, KochKC, RoebE, JanssensU. Health care costs, long-term survival, and quality of life following intensive care unit admission after cardiac arrest. Crit Care2008;12:R92.18638367, Graf J , MühlhoffC, DoigGS, ReinartzS, BodeK, DujardinR, KochKC, RoebE, JanssensU. Health care costs, long-term survival, and quality of life following intensive care unit admission after cardiac arrest. Crit Care2008;12:R92.18638367
C. Semsarian, Carolyn Ho (2019)
Screening children at risk for hypertrophic cardiomyopathy: balancing benefits and harms.European heart journal
( Moak JP , KaskiJP. Hypertrophic cardiomyopathy in children. Heart2012;98:1044–1054.22591735)
Moak JP , KaskiJP. Hypertrophic cardiomyopathy in children. Heart2012;98:1044–1054.22591735Moak JP , KaskiJP. Hypertrophic cardiomyopathy in children. Heart2012;98:1044–1054.22591735, Moak JP , KaskiJP. Hypertrophic cardiomyopathy in children. Heart2012;98:1044–1054.22591735
G. Norrish, G. Norrish, T. Ding, E. Field, E. Field, L. Ziółkowska, I. Olivotto, G. Limongelli, A. Anastasakis, R. Weintraub, R. Weintraub, E. Biagini, L. Ragni, T. Prendiville, Sophie Duignan, K. McLeod, M. Ilina, A. Fernández, R. Bökenkamp, A. Baban, P. Kubuš, P. Daubeney, G. Sarquella-Brugada, G. Sarquella-Brugada, Sergi César, C. Marrone, V. Bhole, C. Medrano, O. Uzun, Elspeth Brown, F. Gran, F. Castro, G. Stuart, G. Vignati, R. Barriales-Villa, L. Guereta, S. Adwani, K. Linter, T. Bharucha, P. García-Pavía, T. Rasmussen, M. Calcagnino, Caroline Jones, H. Wilde, J. Toru-Kubo, T. Felice, J. Mogensen, S. Mathur, Z. Reinhardt, C. O’Mahony, C. O’Mahony, Perry Elliott, Perry Elliott, R. Omar, J. Kaski, J. Kaski (2019)
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids).JAMA cardiology
( Ommen SR , MitalS, BurkeMA, DaySM, DeswalA, ElliottP, EvanovichLL, HungJ, JoglarJA, KantorP, KimmelstielC, KittlesonM, LinkMS, MaronMS, MartinezMW, MiyakeCY, SchaffHV, SemsarianC, SorajjaP. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol2020;76:e159–e240.33229116)
Ommen SR , MitalS, BurkeMA, DaySM, DeswalA, ElliottP, EvanovichLL, HungJ, JoglarJA, KantorP, KimmelstielC, KittlesonM, LinkMS, MaronMS, MartinezMW, MiyakeCY, SchaffHV, SemsarianC, SorajjaP. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol2020;76:e159–e240.33229116Ommen SR , MitalS, BurkeMA, DaySM, DeswalA, ElliottP, EvanovichLL, HungJ, JoglarJA, KantorP, KimmelstielC, KittlesonM, LinkMS, MaronMS, MartinezMW, MiyakeCY, SchaffHV, SemsarianC, SorajjaP. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol2020;76:e159–e240.33229116, Ommen SR , MitalS, BurkeMA, DaySM, DeswalA, ElliottP, EvanovichLL, HungJ, JoglarJA, KantorP, KimmelstielC, KittlesonM, LinkMS, MaronMS, MartinezMW, MiyakeCY, SchaffHV, SemsarianC, SorajjaP. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol2020;76:e159–e240.33229116
J. Mathew, Laura Zahavich, M. Lafreniere-Roula, Judith Wilson, K. George, L. Benson, S. Bowdin, S. Mital (2018)
Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathyClinical Genetics, 93
P. Charron, M. Arad, E. Arbustini, C. Basso, Z. Bilińska, P. Elliott, T. Helio, A. Keren, W. McKenna, L. Monserrat, S. Pankuweit, A. Perrot, C. Rapezzi, A. Ristic, H. Seggewiss, I. Langen, L. Tavazzi (2010)
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.European heart journal, 31 22
K. Dubowy, W. Baden, Stefan Bernitzki, B. Peters (2008)
A practical and transferable new protocol for treadmill testing of children and adults**Cardiology in the Young, 18
G. Norrish, J. Jager, E. Field, Ellie Quinn, H. Fell, E. Lord, M. Cicerchia, J. Ochoa, E. Cervi, P. Elliott, J. Kaski (2019)
Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree RelativesCirculation, 140
( Charron P , AradM, ArbustiniE, BassoC, BilinskaZ, ElliottP, HelioT, KerenA, McKennaWJ, MonserratL, PankuweitS, PerrotA, RapezziC, RisticA, SeggewissH, van LangenI, TavazziL; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Genetic counselling and testing in cardiomyopathies: a position statement of the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J2010;31:2715–2726.20823110)
Charron P , AradM, ArbustiniE, BassoC, BilinskaZ, ElliottP, HelioT, KerenA, McKennaWJ, MonserratL, PankuweitS, PerrotA, RapezziC, RisticA, SeggewissH, van LangenI, TavazziL; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Genetic counselling and testing in cardiomyopathies: a position statement of the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J2010;31:2715–2726.20823110Charron P , AradM, ArbustiniE, BassoC, BilinskaZ, ElliottP, HelioT, KerenA, McKennaWJ, MonserratL, PankuweitS, PerrotA, RapezziC, RisticA, SeggewissH, van LangenI, TavazziL; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Genetic counselling and testing in cardiomyopathies: a position statement of the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J2010;31:2715–2726.20823110, Charron P , AradM, ArbustiniE, BassoC, BilinskaZ, ElliottP, HelioT, KerenA, McKennaWJ, MonserratL, PankuweitS, PerrotA, RapezziC, RisticA, SeggewissH, van LangenI, TavazziL; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Genetic counselling and testing in cardiomyopathies: a position statement of the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J2010;31:2715–2726.20823110
( Morita H , RehmHL, MenessesA, McDonoughB, RobertsAE, KucherlapatiR, TowbinJA, SeidmanJG, SeidmanCE. Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med2008;358:1899–1908.18403758)
Morita H , RehmHL, MenessesA, McDonoughB, RobertsAE, KucherlapatiR, TowbinJA, SeidmanJG, SeidmanCE. Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med2008;358:1899–1908.18403758Morita H , RehmHL, MenessesA, McDonoughB, RobertsAE, KucherlapatiR, TowbinJA, SeidmanJG, SeidmanCE. Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med2008;358:1899–1908.18403758, Morita H , RehmHL, MenessesA, McDonoughB, RobertsAE, KucherlapatiR, TowbinJA, SeidmanJG, SeidmanCE. Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med2008;358:1899–1908.18403758
G. Norrish, E. Field, K. McLeod, M. Ilina, G. Stuart, V. Bhole, O. Uzun, Elspeth Brown, P. Daubeney, A. Lota, K. Linter, S. Mathur, T. Bharucha, K. Kok, S. Adwani, Caroline Jones, Z. Reinhardt, J. Kaski (2018)
Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United KingdomEuropean Heart Journal, 40
N. Marston, Larry Han, I. Olivotto, S. Day, E. Ashley, M. Michels, A. Pereira, J. Ingles, C. Semsarian, D. Jacoby, S. Colan, J. Rossano, S. Wittekind, J. Ware, S. Saberi, A. Helms, Carolyn Ho (2021)
Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathyEuropean Heart Journal, 42
G. Gallo, V. Mastromarino, G. Limongelli, G. Calcagni, A. Maruotti, L. Ragni, F. Valente, M. Musumeci, R. Adorisio, M. Rubino, C. Autore, D. Magrí (2021)
Insights from Cardiopulmonary Exercise Testing in Pediatric Patients with Hypertrophic CardiomyopathyBiomolecules, 11
J. Graf, C. Mühlhoff, G. Doig, S. Reinartz, Kirsten Bode, R. Dujardin, K. Koch, E. Roeb, U. Janssens (2008)
Health care costs, long-term survival, and quality of life following intensive care unit admission after cardiac arrestCritical Care, 12
( Authors/Task Force members, ElliottPM, AnastasakisA, BorgerMA, BorggrefeM, CecchiF, CharronP, HagegeAA, LafontA, LimongelliG, MahrholdtH, McKennaWJ, MogensenJ, NihoyannopoulosP, NistriS, PieperPG, PieskeB, RapezziC, RuttenFH, TillmannsC, WatkinsH. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur Heart J2014;35:2733–2779.25173338)
Authors/Task Force members, ElliottPM, AnastasakisA, BorgerMA, BorggrefeM, CecchiF, CharronP, HagegeAA, LafontA, LimongelliG, MahrholdtH, McKennaWJ, MogensenJ, NihoyannopoulosP, NistriS, PieperPG, PieskeB, RapezziC, RuttenFH, TillmannsC, WatkinsH. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur Heart J2014;35:2733–2779.25173338Authors/Task Force members, ElliottPM, AnastasakisA, BorgerMA, BorggrefeM, CecchiF, CharronP, HagegeAA, LafontA, LimongelliG, MahrholdtH, McKennaWJ, MogensenJ, NihoyannopoulosP, NistriS, PieperPG, PieskeB, RapezziC, RuttenFH, TillmannsC, WatkinsH. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur Heart J2014;35:2733–2779.25173338, Authors/Task Force members, ElliottPM, AnastasakisA, BorgerMA, BorggrefeM, CecchiF, CharronP, HagegeAA, LafontA, LimongelliG, MahrholdtH, McKennaWJ, MogensenJ, NihoyannopoulosP, NistriS, PieperPG, PieskeB, RapezziC, RuttenFH, TillmannsC, WatkinsH. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur Heart J2014;35:2733–2779.25173338
( Dubowy KO , BadenW, BernitzkiS, PetersB. A practical and transferable new protocol for treadmill testing of children and adults. Cardiol Young2008;18:615–623.18838025)
Dubowy KO , BadenW, BernitzkiS, PetersB. A practical and transferable new protocol for treadmill testing of children and adults. Cardiol Young2008;18:615–623.18838025Dubowy KO , BadenW, BernitzkiS, PetersB. A practical and transferable new protocol for treadmill testing of children and adults. Cardiol Young2008;18:615–623.18838025, Dubowy KO , BadenW, BernitzkiS, PetersB. A practical and transferable new protocol for treadmill testing of children and adults. Cardiol Young2008;18:615–623.18838025
( Semsarian C , HoCY. Screening children at risk for hypertrophic cardiomyopathy: balancing benefits and harms. Eur Heart J2019;40:3682–3684.31289813)
Semsarian C , HoCY. Screening children at risk for hypertrophic cardiomyopathy: balancing benefits and harms. Eur Heart J2019;40:3682–3684.31289813Semsarian C , HoCY. Screening children at risk for hypertrophic cardiomyopathy: balancing benefits and harms. Eur Heart J2019;40:3682–3684.31289813, Semsarian C , HoCY. Screening children at risk for hypertrophic cardiomyopathy: balancing benefits and harms. Eur Heart J2019;40:3682–3684.31289813
( Kindel SJ , MillerEM, GuptaR, CripeLH, HintonRB, SpicerRL, TowbinJA, WareSM. Pediatric cardiomyopathy: importance of genetic and metabolic evaluation. J Card Fail2012;18:396–403.22555271)
Kindel SJ , MillerEM, GuptaR, CripeLH, HintonRB, SpicerRL, TowbinJA, WareSM. Pediatric cardiomyopathy: importance of genetic and metabolic evaluation. J Card Fail2012;18:396–403.22555271Kindel SJ , MillerEM, GuptaR, CripeLH, HintonRB, SpicerRL, TowbinJA, WareSM. Pediatric cardiomyopathy: importance of genetic and metabolic evaluation. J Card Fail2012;18:396–403.22555271, Kindel SJ , MillerEM, GuptaR, CripeLH, HintonRB, SpicerRL, TowbinJA, WareSM. Pediatric cardiomyopathy: importance of genetic and metabolic evaluation. J Card Fail2012;18:396–403.22555271
( Sharma S , DreznerJA, BaggishA, PapadakisM, WilsonMG, PrutkinJM, La GercheA, AckermanMJ, BorjessonM, SalernoJC, AsifIM, OwensDS, ChungEH, EmeryMS, FroelicherVF, HeidbuchelH, AdamuzC, AsplundCA, CohenG, HarmonKG, MarekJC, MolossiS, NiebauerJ, PeltoHF, PerezMV, RidingNR, SaarelT, SchmiedCM, ShiponDM, SteinR, VetterVL, PellicciaA, CorradoD. International recommendations for electrocardiographic interpretation in athletes. Eur Heart J2018;39:1466–1480.28329355)
Sharma S , DreznerJA, BaggishA, PapadakisM, WilsonMG, PrutkinJM, La GercheA, AckermanMJ, BorjessonM, SalernoJC, AsifIM, OwensDS, ChungEH, EmeryMS, FroelicherVF, HeidbuchelH, AdamuzC, AsplundCA, CohenG, HarmonKG, MarekJC, MolossiS, NiebauerJ, PeltoHF, PerezMV, RidingNR, SaarelT, SchmiedCM, ShiponDM, SteinR, VetterVL, PellicciaA, CorradoD. International recommendations for electrocardiographic interpretation in athletes. Eur Heart J2018;39:1466–1480.28329355Sharma S , DreznerJA, BaggishA, PapadakisM, WilsonMG, PrutkinJM, La GercheA, AckermanMJ, BorjessonM, SalernoJC, AsifIM, OwensDS, ChungEH, EmeryMS, FroelicherVF, HeidbuchelH, AdamuzC, AsplundCA, CohenG, HarmonKG, MarekJC, MolossiS, NiebauerJ, PeltoHF, PerezMV, RidingNR, SaarelT, SchmiedCM, ShiponDM, SteinR, VetterVL, PellicciaA, CorradoD. International recommendations for electrocardiographic interpretation in athletes. Eur Heart J2018;39:1466–1480.28329355, Sharma S , DreznerJA, BaggishA, PapadakisM, WilsonMG, PrutkinJM, La GercheA, AckermanMJ, BorjessonM, SalernoJC, AsifIM, OwensDS, ChungEH, EmeryMS, FroelicherVF, HeidbuchelH, AdamuzC, AsplundCA, CohenG, HarmonKG, MarekJC, MolossiS, NiebauerJ, PeltoHF, PerezMV, RidingNR, SaarelT, SchmiedCM, ShiponDM, SteinR, VetterVL, PellicciaA, CorradoD. International recommendations for electrocardiographic interpretation in athletes. Eur Heart J2018;39:1466–1480.28329355
H. Morita, H. Rehm, Andres Menesses, B. McDonough, A. Roberts, R. Kucherlapati, J. Towbin, J. Seidman, C. Seidman (2008)
Shared genetic causes of cardiac hypertrophy in children and adults.The New England journal of medicine, 358 18
S. Ommen, S. Mital, Michael Burke, S. Day, A. Deswal, P. Elliott, Lauren Evanovich, J. Hung, J. Joglar, P. Kantor, C. Kimmelstiel, M. Kittleson, M. Link, M. Maron, Matthew Martinez, C. Miyake, H. Schaff, C. Semsarian, P. Sorajja (2020)
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation
J. Kaski, P. Syrris, M. Esteban, S. Jenkins, A. Pantazis, J. Deanfield, W. McKenna, P. Elliott (2008)
Prevalence of Sarcomere Protein Gene Mutations in Preadolescent Children With Hypertrophic CardiomyopathyCirculation: Cardiovascular Genetics, 2
(2014)
ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC)
( Marston NA , HanL, OlivottoI, DaySM, AshleyEA, MichelsM, PereiraAC, InglesJ, SemsarianC, JacobyD, ColanSD, RossanoJW, WittekindSG, WareJS, SaberiS, HelmsAS, HoCY. Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy. Eur Heart J2021;42:1988–1996.33769460)
Marston NA , HanL, OlivottoI, DaySM, AshleyEA, MichelsM, PereiraAC, InglesJ, SemsarianC, JacobyD, ColanSD, RossanoJW, WittekindSG, WareJS, SaberiS, HelmsAS, HoCY. Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy. Eur Heart J2021;42:1988–1996.33769460Marston NA , HanL, OlivottoI, DaySM, AshleyEA, MichelsM, PereiraAC, InglesJ, SemsarianC, JacobyD, ColanSD, RossanoJW, WittekindSG, WareJS, SaberiS, HelmsAS, HoCY. Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy. Eur Heart J2021;42:1988–1996.33769460, Marston NA , HanL, OlivottoI, DaySM, AshleyEA, MichelsM, PereiraAC, InglesJ, SemsarianC, JacobyD, ColanSD, RossanoJW, WittekindSG, WareJS, SaberiS, HelmsAS, HoCY. Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy. Eur Heart J2021;42:1988–1996.33769460
J. Moak, J. Kaski (2012)
Hypertrophic cardiomyopathy in childrenHeart, 98
G. Norrish, G. Kolt, E. Cervi, E. Field, K. Dady, Lidia Ziółkowska, I. Olivotto, S. Favilli, S. Passantino, G. Limongelli, M. Caiazza, M. Rubino, A. Baban, F. Drago, K. McLeod, M. Ilina, R. McGowan, G. Stuart, V. Bhole, O. Uzun, A. Wong, L. Lazarou, Elspeth Brown, P. Daubeney, A. Lota, Grazia Donne, K. Linter, S. Mathur, T. Bharucha, S. Adwani, J. Searle, A. Popoiu, Caroline Jones, Z. Reinhardt, J. Kaski (2021)
Clinical presentation and long‐term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre studyESC Heart Failure, 8
( Mathew J , ZahavichL, Lafreniere-RoulaM, WilsonJ, GeorgeK, BensonL, BowdinS, MitalS. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy. Clin Genet2018;93:310–319.29053178)
Mathew J , ZahavichL, Lafreniere-RoulaM, WilsonJ, GeorgeK, BensonL, BowdinS, MitalS. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy. Clin Genet2018;93:310–319.29053178Mathew J , ZahavichL, Lafreniere-RoulaM, WilsonJ, GeorgeK, BensonL, BowdinS, MitalS. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy. Clin Genet2018;93:310–319.29053178, Mathew J , ZahavichL, Lafreniere-RoulaM, WilsonJ, GeorgeK, BensonL, BowdinS, MitalS. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy. Clin Genet2018;93:310–319.29053178
( Lipshultz SE , SleeperLA, TowbinJA, LoweAM, OravEJ, CoxGF, LuriePR, McCoyKL, McDonaldMA, MessereJE, ColanSD. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med2003;348:1647–1655.12711739)
Lipshultz SE , SleeperLA, TowbinJA, LoweAM, OravEJ, CoxGF, LuriePR, McCoyKL, McDonaldMA, MessereJE, ColanSD. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med2003;348:1647–1655.12711739Lipshultz SE , SleeperLA, TowbinJA, LoweAM, OravEJ, CoxGF, LuriePR, McCoyKL, McDonaldMA, MessereJE, ColanSD. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med2003;348:1647–1655.12711739, Lipshultz SE , SleeperLA, TowbinJA, LoweAM, OravEJ, CoxGF, LuriePR, McCoyKL, McDonaldMA, MessereJE, ColanSD. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med2003;348:1647–1655.12711739
( Lafreniere-Roula M , BolkierY, ZahavichL, MathewJ, GeorgeK, WilsonJ, StephensonEA, BensonLN, ManlhiotC, MitalS. Family screening for hypertrophic cardiomyopathy: is it time to change practice guidelines?Eur Heart J2019;40:3672–3681.31170284)
Lafreniere-Roula M , BolkierY, ZahavichL, MathewJ, GeorgeK, WilsonJ, StephensonEA, BensonLN, ManlhiotC, MitalS. Family screening for hypertrophic cardiomyopathy: is it time to change practice guidelines?Eur Heart J2019;40:3672–3681.31170284Lafreniere-Roula M , BolkierY, ZahavichL, MathewJ, GeorgeK, WilsonJ, StephensonEA, BensonLN, ManlhiotC, MitalS. Family screening for hypertrophic cardiomyopathy: is it time to change practice guidelines?Eur Heart J2019;40:3672–3681.31170284, Lafreniere-Roula M , BolkierY, ZahavichL, MathewJ, GeorgeK, WilsonJ, StephensonEA, BensonLN, ManlhiotC, MitalS. Family screening for hypertrophic cardiomyopathy: is it time to change practice guidelines?Eur Heart J2019;40:3672–3681.31170284
( Kaski JP , SyrrisP, EstebanMT, JenkinsS, PantazisA, DeanfieldJE, McKennaWJ, ElliottPM. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy. Circ Cardiovasc Genet2009;2:436–441.20031618)
Kaski JP , SyrrisP, EstebanMT, JenkinsS, PantazisA, DeanfieldJE, McKennaWJ, ElliottPM. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy. Circ Cardiovasc Genet2009;2:436–441.20031618Kaski JP , SyrrisP, EstebanMT, JenkinsS, PantazisA, DeanfieldJE, McKennaWJ, ElliottPM. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy. Circ Cardiovasc Genet2009;2:436–441.20031618, Kaski JP , SyrrisP, EstebanMT, JenkinsS, PantazisA, DeanfieldJE, McKennaWJ, ElliottPM. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy. Circ Cardiovasc Genet2009;2:436–441.20031618
( Norrish G , JagerJ, FieldE, QuinnE, FellH, LordE, CicerchiaMN, OchoaJP, CerviE, ElliottPM, KaskiJP. Yield of clinical screening for hypertrophic cardiomyopathy in child first-degree relatives. Circulation2019;140:184–192.31006259)
Norrish G , JagerJ, FieldE, QuinnE, FellH, LordE, CicerchiaMN, OchoaJP, CerviE, ElliottPM, KaskiJP. Yield of clinical screening for hypertrophic cardiomyopathy in child first-degree relatives. Circulation2019;140:184–192.31006259Norrish G , JagerJ, FieldE, QuinnE, FellH, LordE, CicerchiaMN, OchoaJP, CerviE, ElliottPM, KaskiJP. Yield of clinical screening for hypertrophic cardiomyopathy in child first-degree relatives. Circulation2019;140:184–192.31006259, Norrish G , JagerJ, FieldE, QuinnE, FellH, LordE, CicerchiaMN, OchoaJP, CerviE, ElliottPM, KaskiJP. Yield of clinical screening for hypertrophic cardiomyopathy in child first-degree relatives. Circulation2019;140:184–192.31006259
S. Lipshultz, L. Sleeper, J. Towbin, A. Lowe, E. Orav, G. Cox, G. Cox, P. Lurie, K. McCoy, Melissa McDonald, Jane Messere, S. Colan (2003)
The incidence of pediatric cardiomyopathy in two regions of the United States.The New England journal of medicine, 348 17
Sanjay Sharma, J. Drezner, A. Baggish, M. Papadakis, Mathew Wilson, J. Prutkin, A. Gerche, M. Ackerman, M. Borjesson, J. Salerno, I. Asif, D. Owens, Eugene Chung, M. Emery, V. Froelicher, H. Heidbuchel, C. Adamuz, C. Asplund, G. Cohen, K. Harmon, J. Marek, S. Molossi, J. Niebauer, H. Pelto, M. Perez, N. Riding, T. Saarel, C. Schmied, D. Shipon, R. Stein, V. Vetter, A. Pelliccia, D. Corrado (2018)
International recommendations for electrocardiographic interpretation in athletesEuropean Heart Journal, 39
S. Kindel, E. Miller, Resmi Gupta, L. Cripe, R. Hinton, R. Spicer, J. Towbin, S. Ware (2012)
Pediatric cardiomyopathy: importance of genetic and metabolic evaluation.Journal of cardiac failure, 18 5
( Gallo G , MastromarinoV, LimongelliG, CalcagniG, MaruottiA, RagniL, ValenteF, MusumeciMB, AdorisioR, RubinoM, AutoreC, MagrìD. Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy. Biomolecules2021;11:376.33801562)
Gallo G , MastromarinoV, LimongelliG, CalcagniG, MaruottiA, RagniL, ValenteF, MusumeciMB, AdorisioR, RubinoM, AutoreC, MagrìD. Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy. Biomolecules2021;11:376.33801562Gallo G , MastromarinoV, LimongelliG, CalcagniG, MaruottiA, RagniL, ValenteF, MusumeciMB, AdorisioR, RubinoM, AutoreC, MagrìD. Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy. Biomolecules2021;11:376.33801562, Gallo G , MastromarinoV, LimongelliG, CalcagniG, MaruottiA, RagniL, ValenteF, MusumeciMB, AdorisioR, RubinoM, AutoreC, MagrìD. Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy. Biomolecules2021;11:376.33801562
BackgroundPaediatric hypertrophic cardiomyopathy (HCM) caused by sarcomere protein gene mutations is more common than previously thought. We present the case of a 9-year-old boy that was diagnosed with HCM during family screening.Case summaryWe present a case of a 9-year-old boy with a family history of sarcomeric HCM who was diagnosed with hypertrophic obstructive cardiomyopathy (HOCM) during clinical screening. Echocardiography and cardiovascular magnetic resonance imaging revealed asymmetric left ventricular hypertrophy with a maximum wall thickness of 18–19 mm. Cardiovascular magnetic resonance late gadolinium enhancement imaging showed patchy fibrosis within the area of maximum wall thickness. Genetic testing confirmed the presence of the familial mutation in the MYL2 gene. The patient was started on bisoprolol. Furthermore, risk stratification was performed and a recommendation for implantable cardioverter-defibrillator implantation was made.DiscussionThis case demonstrates that significant HCM can already start in childhood and discusses the recommendations for family screening on the basis of recently published studies and the present European Society of Cardiology guideline.
European Heart Journal - Case Reports – Oxford University Press
Published: Sep 3, 2022
Keywords: Hypertrophic cardiomyopathy; Sarcomeric protein mutations; Childhood-onset inherited disease; Case report
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.